Start an analysis for DVA
DaVita Inc.
Stock · NYSEProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $1.4bn | 30-Jun-26 | 10-Q filed 29-Oct-26 |
| Remaining authorization | $1.3bn | 30-Jun-26 | 10-Q filed 29-Oct-26 |
| Program expiry | n/a | — | |
| Repurchased last quarter | $111m | 30-Sep-26 | 10-Q filed 29-Oct-26 |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| Not found in filings | $1.4bn | $1.3bn | n/a | As of July 31, 2026, approximately $1,373 million, excluding excise taxes, available under current repurchase authorizations for additional share repurchases. These authorizations do not have an expiration date; we remain subject to share repurchase limitations including under our current senior secured credit facilities.10-Q filed 29-Oct-26 |
Open-market repurchases
- Apr ’26
- May ’26
- Jun ’26
- Jul ’26
- Aug ’26
- Sep ’26
| Month ended | Shares | Avg price | ≈ Value | Source |
|---|---|---|---|---|
| 30-Sep-26 | 231,000 | $182.46 | $42m | 10-Q filed 29-Oct-26 |
| 31-Aug-26 | 180,000 | $177.46 | $32m | 10-Q filed 29-Oct-26 |
| 31-Jul-26 | 183,000 | $199.55 | $37m | 10-Q filed 29-Oct-26 |
| 30-Jun-26 | 232 | $199.55 | $46.3k | 10-Q filed 04-Aug-26 |